三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
2022年中国城市公立医院仑伐替尼品牌竞争格局
2022年中国城市公立医院仑伐替尼品牌竞争格局
竞争格局
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:49KB
图片尺寸:1236*771
同报告图片
/
4
5aW955qE44CCCgp8IOexu+WIqyAgICAgfCDljaDmr5QgICAgfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS18Cnwg5YW25LuWICAgICB8IDIuMDIlICAgfAp8IOm9kOmygeWItuiNryAgIHwgNC4yNyUgICB8Cnwg5Y2X5Lqs5q2j5aSn5aSp5pm05Yi26I2vIHwgNS44NCUgICB8Cnwg5q2j5aSn5aSp5pm06I2v5LiaIHwgNi4zMSUgICB8Cnwg5Y2r5p2QICAgICB8IDgxLjU3JSAgfAoK6LWE5paZ5p2l5rqQ77ya57Gz5YaF572R77yM5aSp6aOO6K+B5Yi456CU56m25omA
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
fOeUn+S6p+S8geS4mnznsbvliKt85Lit5Zu96I635om55LiK5biC5pe26Ze0fOW5tOWMlui0ueeUqO+8iOWNleS9je+8muWFg++8iXznlKjoja/kurrmlbDvvIgyMDIy5bm077yJfAp8LS0tfC0tLXwtLS18LS0tfC0tLXwKfOW+t+WbveaLnOiAs3zljp/noJR8MjAwNi4wOXw0NTYwMHwyMjk1fAp855+z6I2v5qyn5oSPfOS7v+WItnwyMDIxLjA0fDM5ODR8NTMwfAp85rGf6KW/5bGx6aaZfOS7v+WItnwyMDIwLjA4fDc2NjYuNHw4NDEzfAp86YeN5bqG6I2v5Y+LfOS7v+WItnwyMDIwLjA4fDEyMjkuMzZ8MjU5NDh8Cnzml6XmnKzljavmnZB85Y6f56CUfDIwMTguMDl8Nzc3NjB8MTUxMTd8CnzmsZ/opb/lsbHpppl85Lu/5Yi2fDIwMjIuMDN8MTMyNDAuNTZ8Mjc3fAp855+z6I2v5qyn5oSPfOS7v+WItnwyMDIyLjAxfDIwMDMwLjR8NDY1fAp85rGf6IuP5aWl6LWb5bq3fOS7v+WItnwyMDIxLjEyfDYxNDR8OTYyfAp86b2Q6bKB5Yi26I2vfOS7v+WItnwyMDIxLjA5fDkyMTZ8NjY3M3wKfOWFiOWjsOiNr+S4mnzku7/liLZ8MjAyMS4wN3wyMzA0fDM1NTl8CnzmraPlpKflpKnmmbR85Lu/5Yi2fDIwMjEuMDd8MTg5MzZ8NDgwMHwKfOWNl+S6rOato+Wkp+WkqeaZtHzku7/liLZ8MjAyMS4wOHw0MzkyMHwxOTE1fAp85oiQ6YO95YCN54m5fOS7v+WItnwyMDIxLjEwfDE2NTEyfDExOHwKCui1hOaWmeadpea6kO+8muiNr+aZuuaVsOaNru+8jOiNr+iejeS6ke+8jOexs+WGhee9ke+8jOWkqemjjuivgeWIuOeglOeptuaJgCDms6jvvJrntKLmi4npnZ7lsLzlubTljJbotLnnlKjlj4LogINtUEZTPTTkuKrmnIjorqHnrpfvvIzku5HkvJDmm7/lsLzlubTljJbotLnnlKjlj4LogINtUEZTPTjkuKrmnIjorqHnrpc=
所属报告:
泽璟制药-公司研究报告-初具biopharma规模2023年多个品种有望持续兑现-230709(43页).pdf
打包全文图表
相关数据
表10仑伐替尼已经获批适应症以及在研临床试验梳理(黄底为还在进行中的临床试验)
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
收藏
其它
2024-07-10
原图定位
查看详情
索拉非尼及仑伐替尼集采后销售额下滑,多纳非尼市占率提升(百万元)
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
收藏
竞争格局
2024-07-03
原图定位
查看详情
中国城市公立医院仑伐替尼市场规模(单位:百万元)
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
收藏
行业数据
2023-07-10
原图定位
查看详情
中国已上市索拉非尼和仑伐替尼药物概况
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
收藏
行业数据
2023-07-10
原图定位
查看详情
索拉非尼、仑伐替尼国内仿制药众多
fCDpgJrnlKjlkI0gICB8IOS8geS4miAgICAgICAgIHwg5pyA5pep6I635om55pe26Ze0ICB8IOaWsOiNry/ku7/liLboja8gfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tfAp8IOeUsuiLr+ejuumFuOe0ouaLiemdnuWwvOeJhyB8IOadreW3nuS4ree+juWNjuS4nOWItuiNryB8IDIwMjItMTEtMTUgICAgfCDku7/liLboja8gICAgICAgfAp8IOeUsuiLr+ejuumFuOe0ouaLiemdnuWwvOeJhyB8IOefs+iNr+mbhuWbouasp+aEj+iNr+S4miB8IDIwMjEtMDQtMjcgICAgfCDku7/liLboja8gICAgICAgfAp8IOeUsuiLr+ejuumFuOe0ouaLiemdnuWwvOeJhyB8IOWMl+S6rOS6muWuneeUn+eJqeiNr+S4miB8IDIwMjEtMDQtMjAgICAgfCDku7/liLboja8gICAgICAgfAp8IOeUsuiLr+ejuumFuOe0ouaLiemdnuWwvOeJhyB8IOmHjeW6huiNr+WPi+WItuiNryAgICAgfCAyMDIwLTA4LTEyICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLoi6/no7rphbjntKLmi4npnZ7lsLzniYcgfCDmsZ/opb/lsbHpppnoja/kuJogICAgIHwgMjAyMC0wOC0wNSAgICB8IOS7v+WItuiNryAgICAgICB8Cnwg55Sy6Iuv56O66YW457Si5ouJ6Z2e5bC854mHIHwg5ouc6ICz5Yy76I2vICAgICAgICB8IDIwMDYtMDktMTIgICAgfCDmlrDoja8gICAgICAgICB8Cnwg55Sy56O66YW45LuR5LyQ5pu/5bC86IO25ZuKIHwg5oms5a2Q5rGf6I2v5LiaICAgICAgfCAyMDIyLTExLTA4ICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLno7rphbjku5HkvJDmm7/lsLzog7blm4ogfCDmsZ/opb/lsbHpppnoja/kuJogICAgfCAyMDIyLTAzLTIyICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLno7rphbjku5HkvJDmm7/lsLzog7blm4ogfCDnn7Poja/pm4blm6LmrKfmhI/oja/kuJp8IDIwMjItMDEtMDcgICAgfCDku7/liLboja8gICAgICAgfAp8IOeUsuejuumFuOS7keS8kOabv+WwvOiDtuWbiiB8IOa5luWNl+enkeS8puWItuiNryAgICB8IDIwMjEtMTItMTQgICAgfCDku7/liLboja8gICAgICAgfAp8IOeUsuejuumFuOS7keS8kOabv+WwvOiDtuWbiiB8IOaxn+iLj+Wlpei1m+W6t+iNr+S4miAgfCAyMDIxLTEyLTE0ICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLno7rphbjku5HkvJDmm7/lsLzog7blm4ogfCDmiJDpg73lgI3nibnoja/kuJogICAgfCAyMDIxLTEwLTI2ICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLno7rphbjku5HkvJDmm7/lsLzog7blm4ogfCDpvZDpsoHliLboja8gICAgICAgfCAyMDIxLTA5LTEzICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLno7rphbjku5HkvJDmm7/lsLzog7blm4ogfCDlhYjlo7Doja/kuJogICAgICAgfCAyMDIxLTA3LTIwICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLno7rphbjku5HkvJDmm7/lsLzog7blm4ogfCDmraPlpKflpKnmmbQgICAgICAgfCAyMDIxLTA3LTIwICAgIHwg5Lu/5Yi26I2vICAgICAgIHwKfCDnlLLno7rphbjku5HkvJDmm7/lsLzog7blm4ogfCDljavmnZDoja/kuJogICAgICAgfCAyMDE4LTA5LTA0ICAgIHwg5paw6I2vICAgICAgICAgfAoKCui1hOaWmeadpea6kO+8mmluc2lnaHTvvIzkuJzkuprliY3mtbfor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2023-03-10
原图定位
查看详情
索拉非尼、仑伐替尼、多纳非尼基本情况对比
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
收藏
行业数据
2023-03-10
原图定位
查看详情
仑伐替尼中国样本医院销售额(万元)
fCDlubTku70gfCDplIDllK7ph5Hpop3vvIjkuIflhYPvvIkgfCDlop7plb/njofvvIgl77yJIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwKfCAyMDE5IHwgMTM3MC40NSAgICAgICAgfCAtICAgICAgICAgIHwKfCAyMDIwIHwgNTc3MC4yMCAgICAgICAgfCAzMjEuMDQgICAgIHwKfCAyMDIxIHwgNDQwNjcuNTQgICAgICAgfCA2NjMuNzEgICAgIHwKCui1hOaWmeadpea6kO+8mldpbmQg5Yy76I2v5bqT77yM5Lic5Lqa5YmN5rW36K+B5Yi456CU56m25omA
收藏
行业数据
2023-03-10
原图定位
查看详情
仑伐替尼中国样本医院销售量(盒)
fCDlubTku70gfCDplIDllK7ph4/vvIjnm5LvvIkgfCDlop7plb/njofvvIgl77yJIHwKfC0tLS0tLXwtLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IDIwMTkgfCAyNDQ4MiAgICAgIHwgLSAgICAgICAgICB8CnwgMjAyMCB8IDEwMzA1MCAgICAgfCAzMjAuOTIgICAgIHwKfCAyMDIxIHwgMzk2NDc0MCAgICB8IDM3NDcuMzkgICAgfAoK6LWE5paZ5p2l5rqQ77yaV2luZCDljLvoja/lupPvvIzkuJzkuprliY3mtbfor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2023-03-10
原图定位
查看详情
2015-2019年仑伐替尼全球销售额
收藏
行业数据
2020-11-02
原图定位
查看详情
仑伐替尼开发历史
收藏
行业数据
2020-09-15
原图定位
查看详情
仑伐替尼上市后销售额及同比增长
收藏
行业数据
2020-09-15
原图定位
查看详情
2017-2019年仑伐替尼销售额分地区情况
收藏
行业数据
2020-09-15
原图定位
查看详情
国内仑伐替尼生物等效性试验
收藏
行业数据
2020-09-11
原图定位
查看详情
仑伐替尼2018财年日本的销售额仅次于美国(十亿日元,%)
收藏
行业数据
2020-07-31
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
市场药物存量降低,多纳非尼有望填补市场空缺。索拉非尼和仑伐替尼分别于 2021年第4批及 2022 年第 7批纳入国家集中采购目录,销售单价最高分别达到 75%和 97%的降价。索拉非尼和仑伐替尼进入全国药品集中采购可能导致晚期肝癌一线靶向药物及分化型甲状腺癌药物市场存量降低,多纳非尼则有望凭借优效临床的优势填补竞品纳入集采后空缺的市场空间。
竞争格局
原图定位
当前图表所属:
泽璟制药-公司研究报告-初具biopharma规模2023年多个品种有望持续兑现-230709(43页).pdf
泽普凝I/II期临床试验疗效总结
中国临床阶段分化型甲状腺癌竞争格局
中国RAIR-DTC已上市药品竞争格局
中国已上市索拉非尼和仑伐替尼药物概况
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》